CNTFR: A Potential Drug Target for Eye and Age-Related Diseases

Target Name: CNTFR

NCBI ID: G1271

CNTFR

CNTFR: A Potential Drug Target for Eye and Age-Related Diseases

Ciliary neurotrophic factor (CNTFR) is a protein that is expressed in the cilium, which is a specialized type of cell that is found in the inner lining of the eye. The cilium plays a crucial role in maintaining the health and function of the eye, and it is thought to be involved in the development and maintenance of a number of eye diseases, including several forms of blindness.

CNTFR is a member of the neurotrophic factor (NTF) family, which is a group of proteins that are involved in the process of neurotrophic signaling. This family of proteins includes several other well-known proteins, including NTF1, NTF2, and NTF3. Like these other proteins, CNTFR is involved in the survival and growth of cells, and it is thought to play a key role in the development and progression of a number of eye diseases.

Despite the importance of CNTFR in the understanding of eye disease, much is still not known about this protein. In this article, we will explore the biology and function of CNTFR, as well as the potential implications of this protein as a drug target or biomarker.

Biology and Function

CNTFR is a transmembrane protein that is expressed in the cilium. It consists of a pre-伪 chain and a post-伪 chain, which are separated by a transmembrane region. The pre-伪 chain consists of an extracellular portion and a cytoplasmic portion, while the post-伪 chain is entirely cytoplasmic.

The cytoplasmic portion of CNTFR contains a region that is similar to the extracellular domain of NTF1 and NTF2, which are also involved in the NTF family. This region is thought to play a key role in the formation of CNTFR dimers, which are thought to be involved in the regulation of cell survival and growth.

One of the most significant functions of CNTFR is its role in the development and progression of age-related diseases, including age-related macular degeneration (AMD) and cataracts. AMD is a progressive disease that affects the macula, which is the part of the retina that is responsible for central vision, and it is thought to be caused by the buildup of waste material in the macula. CNTFR has been shown to be involved in the development and progression of AMD, and it is potential as a drug target or biomarker for this disease.

CNTFR is also thought to be involved in the development and progression of other age-related diseases, including heart disease and cancer. It has been shown to be involved in the regulation of cell apoptosis, which is the process by which cells die, and it is thought to play a key role in the regulation of cell proliferation.

In addition to its role in age-related diseases, CNTFR is also thought to be involved in the regulation of normal development and function. It has been shown to be involved in the development and maintenance of the nervous system, and it is thought to play a key role in the regulation of sensory perception and behavior.

Potential Therapeutic Applications

The potential therapeutic applications of CNTFR are vast and varied. As a drug target, CNTFR could be used to treat a variety of diseases, including AMD, cataracts, and other forms of blindness. It is thought to be involved in the regulation of cell apoptosis, which could make it an effective target for drugs that are designed to inhibit cell death.

In addition to its potential as a drug, CNTFR is also a potential biomarker for a variety of diseases. Its involvement in the regulation of cell survival and growth makes it an attractive target for therapies that are designed to promote cell survival. This could be useful for the treatment of diseases where cell survival is thought to be a key factor,

Protein Name: Ciliary Neurotrophic Factor Receptor

Functions: Binds to CNTF. The alpha subunit provides the receptor specificity. Receptor for heterodimeric neurotropic cytokine composed of CLCF1/CLC and CRLF1/CLF-1 (PubMed:26858303). Acts as a receptor for the neuroprotective peptide humanin as part of a complex with IL6ST/GP130 and IL27RA/WSX1 (PubMed:19386761)

The "CNTFR Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CNTFR comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets